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Influenza: Quantifying Morbidity and Mortality 
ARNOLD S. MONTO, M.D. 
Ann Arbor, Michigan 
Because of their dramatic impact, morbidity and mortality associ- 
ated with influenza have been recognized since at least the time of 
Elizabeth I of England. Excess mortality has been documented 
since 1889, and the infamous 1918 outbreak confirmed that influ- 
enza was truly one of the last major plagues. Despite the clear rec- 
ognition of large clusters of influenza activity, it is still difficult to 
quantify precisely the total impact of influenza morbidity and mor- 
tality, since laboratory confirmation is required for exact diagnosis. 
Many methods have been developed to provide estimates of the 
mortality associated with influenza. These methods are usually 
predicated on establishing expected baseline rates of mortality. 
Deaths in excess of these rates are then calculated-and attributed 
to the circulating influenza virus. In this way, groups at high risk of 
mortality have been defined as the elderly and those with chronic 
conditions. Special-risk groups, such as those in institutions, have 
also been identified. The quantification of morbidity has required 
different approaches, and here community and family studies have 
made major contributions. In contrast to mortality, morbidity is 
most pronounced in children and young adults, and the diseases, 
although self-limited, are often quite severe. Although the size of the 
outbreaks varies, influenza infection can be documented annually. 
Thus, each year must be considered an influenza year. 
Like the Roman god Janus with his two faces, influenza has two appear- 
ances. To the average lay person, who may not have experienced influ- 
enza for several years, the disease does not seem a major concern or 
problem. To those physicians who are involved with the care of the elderly 
or of those in institutions, on the other hand, the lethal consequences of 
influenza are well known. During an outbreak, many physicians come to 
appreciate the major disruption-and the potentially severe morbidity- 
associated with influenza even in the healthy. This is especially true of 
those who work in student health services. Given these two views of 
Influenza, our task is to examine the existing data and to draw conclu- 
sions so that we can better understand the methods recommended for 
the prevention and treatment of influenza. 
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of Michigan, School of Public Health, Ann Arbor, 
Michigan. Requests for reprints should be ad- 
dressed to Dr. Arnold S. Monto, School of Public 
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gan 48109. 
INFLUENZA FROM A HISTORICAL PERSPECTIVE 
The two views of influenza go back to the first clear description. During 
the time of Elizabeth I of England, an outbreak of what we now believe 
was influenza struck the Scottish court in Edinburgh [l]. The English 
ambassador sent a report back, making light of the suffering of certain 
persons, but at the same time giving clear evidence that this was a wide- 
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?gure 1. Weekly death rate per million of population from influenza and nontuberculous respiratory diseases in New York City, 
1889 to 1898. Data are from the Prudential Life Insurance Company. 
spread disease with a high occurrence rate and consider- 
able severity. It is precisely because of this overall impact 
that influenza can be tracked through history, especially 
when it occurred in pandemic form. 
The first pandemic for which we have good public 
health records occurred in 1889, and the most complete 
data come from certain areas of the United States as well 
as from the Registrar General of England and Wales. Fig 
ure 1 shows the weekly death rate in New York City during 
1‘889-1898, as reflected in data gathered by the Pruden- 
tial Insurance Company [2]. The data are presented for 
influenza alone and for influenza combined with other 
nontuberculous respiratory diseases. The curves are in- 
teresting in two respects. They clearly show both the ef- 
fect of the 1889-l 890 pandemic on mortality and the ap- 
pearance of a second epidemic wave in 1891. They also 
show that death specifically attributed to influenza consti- 
tuted only a small portion of the deaths from respiratory 
disease during the epidemic-most of which was un- 
doubtedly influenza related. This latter finding is still ap- 
parent in today’s statistics. 
Epidemics of influenza were recognizable in various 
winters through the start of World War I, with some histor- 
ians recognizing a possible pandemic in 1900. There has 
never been any question concerning the great pandemic 
of 1918, except perhaps about the likelihood of a recur- 
rence. The mortality in 1918 was enormous, and the esti- 
mate of deaths is approximately 20 million worldwide; 
548,000 deaths occurred in the United States alone, as 
estimated by the United States Bureau of the Census [2]. 
The outbreak came at the end of the war in Europe, but 
deaths were not limited to the military; they occurred 
throughout the civilian population as well. Because of the 
accompanying high morbidity, essential services were 
heavily affected. The situation affected almost all who 
lived through it because of the high mortality; most fami- 
lies experienced either a death or a life-threatening ill- 
ness. 
The 1918 pandemic was a result of the appearance of a 
new type A influenza variant, which seroepidemiologic 
studies have identified as related to swine influenza. The 
reason behind the extreme mortality associated with 
these swine-like viruses has never been satisfactorily de- 
termined, but the age-specific pattern of mortality is clear. 
Age-specific mortality curves can be constructed for a 
number of influenza pandemics. All pandemics, including 
the 1889 outbreak previously described and those after 
1918, including 1957 and 1968, showed a U-shaped pat- 
tern: modestly increased case fatality in the very young 
and then increasing case fatality with increasing age [3]. 
The 1918 outbreak was totally dissimilar, with high fatality 
seen in young adults. The W-shaped curve of 1918 docu- 
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‘gure 3. Influenza surveillance in the United States, 1979- 
1980. Top, laboratory surveillance for influenza infections; 
middle, deaths attributed to pneumonia and influenza in 117 
cities; bottom, reports of influenza activity telephoned to the 
Centers for Disease Control. 
ments the devastating impact of this pandemic, in which 
mortality was not restricted to extremes of age. 
Following 1918, pandemics of type A viruses continued 
to occur-with high occurrence rates, but with mortality 
Figure 2. Clinical influenza occurrence 
rate (Kansas City, 1957) and annual mor- 
tality rate for pneumonia and influenza 
(United States, 1957). 
restricted to what are now recognized as traditional risk 
groups at the extremes of age. Quantification of influenza 
morbidity was becoming more sophisticated, and during 
the 1957 outbreak, clinical influenza was defined on the 
basis of a series of symptoms among residents of Kansas 
City [4]. Figure 2 shows the age-specific clinical occur- 
rence rates; for comparison, the case fatality data in the 
same outbreak are also shown. We now know that clinical 
influenza-influenza defined by a set of symptoms-can 
be recognized reasonably well during an outbreak in all 
except the young, so the curve in Figure 2 underestimates 
the occurrence of disease in very young children. How- 
ever, the basic pattern still holds: morbidity occurs mainly 
in young individuals, including young adults, whereas 
mortality occurs in the elderly. Thus, any policy directed 
toward controlling mortality only in high-risk populations 
will not affect the high frequency of uncomplicated dis- 
ease in the balance of the population. 
The 1957 and 1988 pandemics also allowed the first 
clear documentation of the spread of the new virus. In 
1957, for instance, the disease started in the Orient, and 
the early spread involved countries of the Pacific basin, 
the Middle East, and South America [5]. Outbreaks in the 
United States generally did not occur until the autumn, 
when schools opened; an exception was a Soy Scout 
Jamboree, held in Iowa, from which early seeding took 
place. Similar diagrams can be constructed for the early 
spread of type A (Hl Nl ) influenza during 1977-1978. 
MACROEPIDEMIOLOGY OF INFLUENZA: MORTALITY 
By examining the history of influenza, we have already 
learned a great deal about the mortality associated with 
type A infections. As in all estimates of cause-specific 
mortality, large groups must be followed to determine the 
numbers involved. Nationally, a rapid monitoring of mor- 
tality is maintained by the Centers for Disease Control 
through weekly reporting of deaths attributed to pneumo- 
nia and influenza from approximately 120 cities through- 
out the country [8]. An expected number of deaths is plot- 
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ted for the country as a whole and for nine regions as well, 
and an epidemic threshold is calculated for each. When 
deaths exceed this threshold, especially for a sustained 
time period, an epidemic is deemed to be under way. 
It is important to realize that these data are based on 
clinical evaluation of causes of death, and not on virologic 
results. For example, during the years of 1973-l 978, two 
major type A outbreaks took place: 1975-l 976 and 1977- 
1978; both were reflected in excess mortality nationally. 
Since outbreaks are rarely uniform throughout the coun- 
try, the excess mortality was observed in some regions 
but not in others [7]. Not seen in any of these curves is 
evidence for the major type B activity in 1976-l 977. That 
is because excess mortality is not a regular occurrence 
with type B outbreaks, as it is with type A activity. This 
latter relationship is so pronounced that excess mortality 
can be taken as an indirect indicator of type A (now A 
[H3N2]) transmission. 
However, excess mortality is not always absent in type 
B outbreaks. Once or twice every decade, type B epidem- 
ics do produce detectable excess mortality. This occurred 
during 1979-l 980, and in Figure 3 the association of iso- 
lation of type B viruses with excess mortality can be noted 
[8]. Also, by comparing the bottom panel, reports of out- 
breaks, with the panel on excess mortality, the lag in oc- 
currence of deaths can be observed. This delay of about 
two weeks between onset of illnesses and death has been 
recognized in general for influenza for many years. 
The occurrence of influenza outbreaks over time shows 
how excess mortality can be used as an indirect indicator 
of type A activity especially. These data do not tell us who 
is dying of influenza, although the historical data give us a 
strong suggestion. Contemporary studies have defined 
these high-risk groups: groups not necessarily at high risk 
of infection with influenza, but at high risk for death should 
they contract the disease. 
All of these estimates have required the establishment 
of a baseline level, i.e., the frequency of the event that 
would have existed without the occurrence of influenza in 
the specific time period. A baseline is required because of 
the lack of specific virologic diagnosis in most of the 
cases. Use of such methods probably underestimates the 
impact of epidemic influenza, but is more precise than at- 
tributing all respiratory events in an influenza period to 
influenza. 
Using this technique, Barker and Mullooly [9] examined 
severe life-threatening disease in subscribers to the Kai- 
ser Foundation Health Plan. Data were summarized cal- 
culating the rates of hospitalization for pneumonia and in- 
fluenza per 100,000 in two type A periods, and subtracting 
from each the number of deaths in a baseline reference 
period without influenza. As would be expected, all age 
and risk groups had excess hospitalizations during these 
periods, but the magnitude of the increase differed. The 
definition of high-risk conditions used was taken from the 
Public Health Service vaccine recommendations. Adults 
without high-risk conditions up to age 64 had a lower rate 
of excess hospitalization, whereas all persons with high- 
risk conditions had a much higher rate. Even those over 
65 without such high-risk conditions were at varyingly but 
definitely increased risk of hospitalization. 
These results explain the case-fatality curves that have 
existed since such data were available-that is, with mor- 
tality rising from age 45 because of increased numbers of 
persons with high-risk conditions in the population, and 
then increasing sharply at age 65. They also support the 
basic thrust of the immunization policy in the United 
States, since it is directed mainly toward control of mortal- 
ity. 
MlCROEPlDEMlOLOGY OF INFLUENZA: MORBIDITY 
For many years, it has been said of influenza that many 
sicken but few die. We have seen that death rates can be 
substantial, so morbidity at these times must be very large 
indeed. Although estimating mortality rates has required 
use of relatively large populations, morbidity estimates 
can be made with smaller populations, in which clinical 
observations are supported by laboratory studies. Investi- 
gations in Houston have documented the need for careful 
virologic confirmation in identifying causes of morbidity 
[lo]. The numbers of patients with respiratory diseases 
presenting to surveillance sites and of influenza virus iso- 
lates during the winter of 1980-1981 were compared. 
Disease rates peaked at the time two A subtypes of influ- 
enza (A H3N2 and A Hl Nl) circulated. The numbers sug- 
gest that type A influenza was responsible for even more 
than the excess above the baseline level of illnesses, but 
this is difficult to confirm from these data alone. The disap- 
pearance of other agents in the time period suggests that 
this is indeed the case. 
In our studies in the community of Tecumseh, Michigan, 
we have combined virus isolation with identification of in- 
fection serologically, in an effort to define virus activity 
comprehensively. Illness data are collected prospectively, 
generally by telephone call, from a sample of community 
residents [ll]. This method allows rates of disease and 
infection to be calculated. Figure 4 shows viral isolation 
frequencies for five years of the study in specimens col- 
lected from patients with respiratory disease. The left 
panel shows the percentage of specific viruses in speci- 
mens showing positive results for viruses from the com- 
munity surveillance. In this surveillance, illnesses of any 
severity were sampled. The right panel shows the same 
distribution in specimens collected by community physi- 
cians from their patients. The difference in frequency of 
influenza isolations is striking, and it is a result of the 
greater severity of influenza-related diseases, which lead 
to physician consultations. Both panels are for illnesses 
occurring anytime in the year, not simply for those speci- 
mens collected during influenza outbreaks. They also are 
for all age groups. Even in the left panel (surveillance 
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group), influenza isolates for all ages accounted for close 
to 30 percent of specimens yielding positive results. When 
analysis is restricted to isolates from persons of school 
age (ages five to 19 years) in the group under surveil- 
lance, it is found that this proportion increases to nearly 50 
percent. 
Another way to assess the impact of influenza is to ex- 
amine the characteristics of the disease associated with 
virus isolation. It should be remembered that much of the 
clinical disease occurs in children and young adults, which 
can be confirmed by examining infection rates for each of 
the types or subtypes in question [12]. The serologic rates 
of infection for type A influenza (H3N2) show a high, flat 
pattern through childhood, remaining high but decreasing 
somewhat in adulthood. This calls to mind the clinically 
determined curve of age-specific disease from Kansas 
City in 1957 (Figure 2). For type B influenza, rates in the 
five- to lCyear-old age group were similar to those for 
type A influenza (H3N2), but in adults the rates of type B 
infection were much lower. For type A (Hl Nl), the pattern 
was generally similar to that of type B. The cut off in the 
mid-20s age group, at least for the clinical disease, was 
even more striking than with type B. 
Referring again to disease, we see in Table I three indi- 
cators of severity determined for each influenza virus type 
or subtype, plus the median duration of the illnesses. Be- 
cause of difference in disease characteristics by age, the 
results are divided into those for children and those for 
adults. The proportion of patients with lower respiratory 
symptoms (productive cough, pain on respiration, wheez- 
ing) was the same for the three virus types in children but 
was highest for type A (H3N2) in adults. The pattern for 
fever (generally more common in children than in adults) 
was not as consistent, but physician consultation was 
again most common for type A (H3N2). This and the dura- 
tion of disease do give an indication of the morbidity 
caused by influenza. The duration was longest for type A 
(H3N2), next for type B, and shortest for type A (Hl Nl). 
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Even here, the duration of disease was relatively long- 
seven days in children and 10 days in the few young 
adults infected. 
COMMENTS 
Overall, there is enormous morbidity from influenza. The 
disease is relatively severe and leads to physician consul- 
tations. The physician must then decide how to handle a 
large number of cases in the course of an outbreak. 
Outbreaks of influenza are easy to recognize in most 
cases, although in certain years transmission may be less 
dramatic than in others [13]. Because of the higher mor- 
bidity in the young, the existence of an outbreak is easier 
to recognize when young people are being seen. In any 
event, whether or not the outbreak is dramatic, it is impor- 
tant to realize that influenza occurs every winter, and that 
predictions of outbreaks have been notoriously poor. The 
national recommendations for vaccine usage acknowl- 
edge this fact by calling for annual vaccination of specific 
groups. The major intent of these recommendations is to 
control mortality by vaccinating those at high risk of death 
should they become infected. Higher morbidity in other 
populations is in part recognized by calling for vaccination 
of non-high-risk persons who are in close contact with 
high-risk persons and who could transmit the infection. 
Also recognized is the fact that clusters of susceptible per- 
sons increase the likelihood of transmission [14]. There is 
at present no recommendation for controlling the bulk of 
morbidity by vaccination with currently available vaccines. 
This means that high morbidity can still be expected to 
occur in outbreaks, and we must be prepared to care for 
those patients with appropriate therapy, which can include 
amantadine. 
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